Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.8000
-0.0762 (-8.70%)
At close: Apr 1, 2026, 4:00 PM EDT
0.8300
+0.0300 (3.75%)
After-hours: Apr 1, 2026, 7:18 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $22.39 million as of April 1, 2026. Its market cap has decreased by -73.62% in one year.
Market Cap
22.39M
Enterprise Value
-4.51M
1-Year Change
-73.62%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $22.39M, a decrease of -81.76%. That is a compound annual growth rate of -23.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 24.52M | -52.12% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 25.24M |
| Plus Therapeutics | 25.12M |
| AEON Biopharma | 24.92M |
| Vistagen Therapeutics | 24.17M |
| Neuphoria Therapeutics | 23.99M |
| Tempest Therapeutics | 23.31M |
| Marker Therapeutics | 22.26M |
| Barinthus Biotherapeutics | 22.06M |